Resistant Starch for Blood Sugar Regulation

Research suggests that resistant starch may support blood sugar regulation through its fermentation in the colon and production of short-chain fatty acids, with review-level evidence indicating that various processing techniques can increase resistant starch content in foods to potentially deliver these effects. The available evidence on this topic consists primarily of two reviews from 2024 and 2025 that focus on production and processing methods rather than direct clinical outcomes in humans, meaning the current literature is more descriptive of mechanism and manufacturing potential than of measured effects on blood sugar in controlled trials. It is also worth noting that three of the five studies provided — examining a diabetes drug mechanism, a fungal cell wall component, and sore throat inflammation — are unrelated to resistant starch and do not contribute evidence to this question. Overall, while the mechanistic rationale for resistant starch and blood sugar regulation is scientifically plausible and supported by the review literature, the studies linked here do not include randomized controlled trials or meta-analyses directly measuring glycemic outcomes in humans, so readers should be aware that the strength of the clinical evidence base as represented here is limited.